Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 9.07
(3.66%)
CNY 9.07
(3.66%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 412.92 Million CNY | 70.61% |
| 2022 | 242.02 Million CNY | 120.16% |
| 2021 | 109.93 Million CNY | 167.85% |
| 2020 | 41.04 Million CNY | -8.71% |
| 2019 | 44.95 Million CNY | -37.56% |
| 2018 | 72 Million CNY | 15.22% |
| 2017 | 62.48 Million CNY | 3.12% |
| 2016 | 60.6 Million CNY | 10.42% |
| 2015 | 54.88 Million CNY | -27.45% |
| 2014 | 75.64 Million CNY | 7.29% |
| 2013 | 70.5 Million CNY | 42.42% |
| 2012 | 49.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 334.39 Million CNY | -21.96% |
| 2024 Q3 | 422.17 Million CNY | -9.62% |
| 2024 Q1 | 428.48 Million CNY | 3.77% |
| 2023 Q2 | 310.75 Million CNY | -6.43% |
| 2023 Q1 | 332.1 Million CNY | 37.22% |
| 2023 Q3 | 310.82 Million CNY | 0.02% |
| 2023 FY | 412.92 Million CNY | 70.61% |
| 2023 Q4 | 412.92 Million CNY | 32.85% |
| 2022 Q4 | 242.02 Million CNY | -15.1% |
| 2022 Q3 | 285.08 Million CNY | -0.01% |
| 2022 FY | 242.02 Million CNY | 120.16% |
| 2022 Q1 | 168.89 Million CNY | 53.64% |
| 2022 Q2 | 285.11 Million CNY | 68.81% |
| 2021 FY | 109.93 Million CNY | 167.85% |
| 2021 Q3 | 54.85 Million CNY | 56.59% |
| 2021 Q1 | 35.03 Million CNY | -14.63% |
| 2021 Q2 | 35.03 Million CNY | -0.01% |
| 2021 Q4 | 109.93 Million CNY | 100.39% |
| 2020 Q1 | 27.04 Million CNY | -39.85% |
| 2020 FY | 41.04 Million CNY | -8.71% |
| 2020 Q2 | 6 Million CNY | -77.79% |
| 2020 Q3 | 31.02 Million CNY | 416.73% |
| 2020 Q4 | 41.04 Million CNY | 32.27% |
| 2019 Q3 | 29 Million CNY | 480.0% |
| 2019 FY | 44.95 Million CNY | -37.56% |
| 2019 Q1 | 102 Million CNY | 41.67% |
| 2019 Q4 | 44.95 Million CNY | 55.03% |
| 2019 Q2 | 5 Million CNY | -95.1% |
| 2018 Q2 | 71.95 Million CNY | 26.34% |
| 2018 FY | 72 Million CNY | 15.22% |
| 2018 Q1 | 56.95 Million CNY | 0.0% |
| 2018 Q4 | 72 Million CNY | -19.96% |
| 2018 Q3 | 89.95 Million CNY | 25.02% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | 62.48 Million CNY | 3.12% |
| 2017 Q1 | 93.65 Million CNY | 54.54% |
| 2017 Q2 | 25 Million CNY | -73.3% |
| 2017 Q3 | - CNY | -100.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 60.6 Million CNY | 10.42% |
| 2016 Q4 | 60.6 Million CNY | 0.0% |
| 2015 Q1 | 68.59 Million CNY | 0.0% |
| 2015 FY | 54.88 Million CNY | -27.45% |
| 2014 FY | 75.64 Million CNY | 7.29% |
| 2013 FY | 70.5 Million CNY | 42.42% |
| 2012 FY | 49.5 Million CNY | 0.0% |